155 related articles for article (PubMed ID: 35655041)
21. Characterisation of a Novel Cell Line (ICR-SS-1) Established from a Patient-Derived Xenograft of Synovial Sarcoma.
Kerrison WGJ; Ning J; Krasny L; Arthur A; Guljar N; Elms ML; Swain A; Jones RL; Thway K; Huang PH
Cells; 2022 Aug; 11(15):. PubMed ID: 35954262
[TBL] [Abstract][Full Text] [Related]
22. Establishment and characterization of NCC-LMS3-C1: a novel patient-derived cell line of leiomyosarcoma.
Yoshimatsu Y; Noguchi R; Osaki J; Sin Y; Tsuchiya R; Ono T; Akiyama T; Adachi Y; Tanzawa Y; Yoshida A; Kawai A; Kondo T
Hum Cell; 2024 Jan; 37(1):337-344. PubMed ID: 37907774
[TBL] [Abstract][Full Text] [Related]
23. Mediastinal Synovial Sarcoma: Clinicopathologic Analysis of 21 Cases With Molecular Confirmation.
Terra SBSP; Aesif SW; Maleszewski JJ; Folpe AL; Boland JM
Am J Surg Pathol; 2018 Jun; 42(6):761-766. PubMed ID: 29543673
[TBL] [Abstract][Full Text] [Related]
24. Establishment and characterization of NCC-ASPS1-C1: a novel patient-derived cell line of alveolar soft-part sarcoma.
Yoshimatsu Y; Noguchi R; Tsuchiya R; Sei A; Sugaya J; Fukushima S; Yoshida A; Kawai A; Kondo T
Hum Cell; 2020 Oct; 33(4):1302-1310. PubMed ID: 32648033
[TBL] [Abstract][Full Text] [Related]
25. The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis.
Jones KB; Barrott JJ; Xie M; Haldar M; Jin H; Zhu JF; Monument MJ; Mosbruger TL; Langer EM; Randall RL; Wilson RK; Cairns BR; Ding L; Capecchi MR
Oncogene; 2016 Sep; 35(38):5021-32. PubMed ID: 26947017
[TBL] [Abstract][Full Text] [Related]
26. Novel characteristics for immunophenotype, FISH pattern and molecular cytogenetics in synovial sarcoma.
Zhong LL; Huang GX; Xian LY; Wei ZC; Tang ZP; Chen QY; Chen H; Tang F
Sci Rep; 2023 May; 13(1):7954. PubMed ID: 37193761
[TBL] [Abstract][Full Text] [Related]
27. Establishment of a novel patient-derived Ewing's sarcoma cell line, NCC-ES1-C1.
Oyama R; Kito F; Qiao Z; Sakumoto M; Noguchi R; Takahashi M; Toki S; Tanzawa Y; Yoshida A; Kawai A; Kondo T
In Vitro Cell Dev Biol Anim; 2018 Dec; 54(10):770-778. PubMed ID: 30324244
[TBL] [Abstract][Full Text] [Related]
28. Release of circulating tumor cells and cell-free nucleic acids is an infrequent event in synovial sarcoma: liquid biopsy analysis of 15 patients diagnosed with synovial sarcoma.
Mihály D; Nagy N; Papp G; Pápai Z; Sápi Z
Diagn Pathol; 2018 Oct; 13(1):81. PubMed ID: 30326929
[TBL] [Abstract][Full Text] [Related]
29. BCOR upregulation in a poorly differentiated synovial sarcoma with SS18L1-SSX1 fusion-A pathologic and molecular pitfall.
Kao YC; Sung YS; Zhang L; Kenan S; Singer S; Tap WD; Swanson D; Dickson BC; Antonescu CR
Genes Chromosomes Cancer; 2017 Apr; 56(4):296-302. PubMed ID: 27914109
[TBL] [Abstract][Full Text] [Related]
30. Establishment and characterization of a novel cell line, NCC-MFS1-C1, derived from a patient with myxofibrosarcoma.
Kito F; Oyama R; Sakumoto M; Shiozawa K; Qiao Z; Toki S; Yoshida A; Kawai A; Kondo T
Hum Cell; 2019 Apr; 32(2):214-222. PubMed ID: 30737712
[TBL] [Abstract][Full Text] [Related]
31. Synovial sarcoma: defining features and diagnostic evolution.
Thway K; Fisher C
Ann Diagn Pathol; 2014 Dec; 18(6):369-80. PubMed ID: 25438927
[TBL] [Abstract][Full Text] [Related]
32. A novel fusion gene, SS18L1/SSX1, in synovial sarcoma.
Storlazzi CT; Mertens F; Mandahl N; Gisselsson D; Isaksson M; Gustafson P; Domanski HA; Panagopoulos I
Genes Chromosomes Cancer; 2003 Jun; 37(2):195-200. PubMed ID: 12696068
[TBL] [Abstract][Full Text] [Related]
33. SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.
Kawai A; Woodruff J; Healey JH; Brennan MF; Antonescu CR; Ladanyi M
N Engl J Med; 1998 Jan; 338(3):153-60. PubMed ID: 9428816
[TBL] [Abstract][Full Text] [Related]
34. SS18-SSX-Dependent YAP/TAZ Signaling in Synovial Sarcoma.
Isfort I; Cyra M; Elges S; Kailayangiri S; Altvater B; Rossig C; Steinestel K; Grünewald I; Huss S; Eßeling E; Mikesch JH; Hafner S; Simmet T; Wozniak A; Schöffski P; Larsson O; Wardelmann E; Trautmann M; Hartmann W
Clin Cancer Res; 2019 Jun; 25(12):3718-3731. PubMed ID: 30814111
[TBL] [Abstract][Full Text] [Related]
35. SS18-SSX fusion protein-induced Wnt/β-catenin signaling is a therapeutic target in synovial sarcoma.
Trautmann M; Sievers E; Aretz S; Kindler D; Michels S; Friedrichs N; Renner M; Kirfel J; Steiner S; Huss S; Koch A; Penzel R; Larsson O; Kawai A; Tanaka S; Sonobe H; Waha A; Schirmacher P; Mechtersheimer G; Wardelmann E; Büttner R; Hartmann W
Oncogene; 2014 Oct; 33(42):5006-16. PubMed ID: 24166495
[TBL] [Abstract][Full Text] [Related]
36. Synovial sarcoma is a stem cell malignancy.
Naka N; Takenaka S; Araki N; Miwa T; Hashimoto N; Yoshioka K; Joyama S; Hamada K; Tsukamoto Y; Tomita Y; Ueda T; Yoshikawa H; Itoh K
Stem Cells; 2010 Jul; 28(7):1119-31. PubMed ID: 20518020
[TBL] [Abstract][Full Text] [Related]
37. Synovial Sarcoma: Current Concepts and Future Perspectives.
Stacchiotti S; Van Tine BA
J Clin Oncol; 2018 Jan; 36(2):180-187. PubMed ID: 29220290
[TBL] [Abstract][Full Text] [Related]
38. Synovial sarcoma: recent discoveries as a roadmap to new avenues for therapy.
Nielsen TO; Poulin NM; Ladanyi M
Cancer Discov; 2015 Feb; 5(2):124-34. PubMed ID: 25614489
[TBL] [Abstract][Full Text] [Related]
39. Synovial Sarcoma: A Clinical Review.
Gazendam AM; Popovic S; Munir S; Parasu N; Wilson D; Ghert M
Curr Oncol; 2021 May; 28(3):1909-1920. PubMed ID: 34069748
[TBL] [Abstract][Full Text] [Related]
40. Establishment and characterization of NCC-ASPS2-C1: a novel patient-derived cell line of alveolar soft part sarcoma.
Osaki J; Noguchi R; Yanagihara K; Ono T; Adachi Y; Iwata S; Toda Y; Sekita T; Kobayashi E; Kojima N; Yoshida A; Kawai A; Kondo T
Hum Cell; 2024 May; 37(3):865-873. PubMed ID: 38478355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
